| Name | | |
| Last NAV | 65.07 | 42.93 |
| Date of Valuation | 2025/08/21 | 2025/08/21 |
| Sharpe Ratio | -0.09 | N/A |
| 3-Year Risk Return Ratio | 1.21 | 0.61 |
| Cumulative Performance (%) |
| +11.92% | +11.02% |
| +22.91% | +19.52% |
| +39.19% | +6.61% |
| +68.05% | +9.38% |
| +6.46% | +17.29% |
| -10.59% | -17.36% |
| +34.55% | +33.53% |
| N/A | +329.30% |
| Calendar Year Performance (%) |
| +6.46% | +17.29% |
| -17.00% | -12.51% |
| -10.59% | -17.36% |
| +28.38% | +27.52% |
| +34.55% | +33.53% |
| 3-Year Annualised Volatility | 27.47% | 17.70% |
| Funds House | BlackRock Asset Management North Asia Limited | Franklin Templeton Investments (Asia) Ltd |
| Portfolio Manager | Evy Hambro & Tom Holl | Evan McCulloch & Wendy Lam & Akiva Felt |
| Funds Type | Equity Funds | Equity Funds |
| Funds Size | USD 4468870000 | USD 1590000000 |
| Base Currency | USD | USD |
| Sector | Gold & Precious Metals | Biotechnology |
| Geographic Allocation | Global | US |
| Top Holdings |
| AGNICO EAGLE MINES LTD (ONTARIO) (8.32%) | AMGEN INC (8.16%) |
| BARRICK GOLD CORP (8.19%) | REGENERON PHARMACEUTICALS INC (7.13%) |
| NEWMONT CORPORATION (6.86%) | VERTEX PHARMACEUTICALS INC (5.83%) |
| KINROSS GOLD CORP (6.17%) | INSMED INC (3.82%) |
| NORTHERN STAR RESOURCES LTD (4.99%) | GILEAD SCIENCES INC (3.69%) |
| ALAMOS GOLD INC (PRE-REINCORPORATION) (4.76%) | ASTRAZENECA PLC (2.92%) |
| SPROTT PHYSICAL SILVER TRUST (4.13%) | INTRA-CELLULAR THERAPIES INC (2.84%) |
| WHEATON PRECIOUS METALS CORP (4.06%) | BIOGEN INC (2.74%) |
| LUNDIN GOLD INC (3.86%) | MERUS NV (2.73%) |
| ENDEAVOUR MINING PLC (5.43%) | ARGENX SE (2.68%) |
| Minimum Initial Investment | N/A | USD 1000 |
| Initial Sales Fee | Class A Shares: up to 5% of the price of shares.Class C Shares: Nil | Class A: Up to 5.00%. Class B: Nil |
| Switching Fee | Nil(A 2% charge on redemptions/conversions may be levied where excessive trading by a shareholder is suspected.), except a delayed Initial Charge of up to 5% of the price of Class A Shares may be payable upon switching newly acquired Shares in a Reserve Fund into this Fund. | Class A: 1.00%. Class B: Nil |
| Maintenance Fee | Custodian Fees Safekeeping fees: 0.005% to 0.441%.Custodian Fees Transactional fees: US$8.8 to US$196 per transaction.Performance Fee : Nil.Administration Fee : Up to 0.25%(May be increased to a combined 2.25% maximum upon giving three months’ prior notice to shareholders.).Distribution Fee Class A Shares: Nil.Distribution Fee Class C Shares: 1.25%. | Custodian fee Class A: Up to 0.14% ( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Custodian fee Class B: Up to 0.14%( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Maintenance charge Class A: Up to 0.50%. Maintenance charge Class B: Up to 0.75%. Servicing charge Class A: Nil. Servicing charge Class B: 1.06%. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class A: Up to 0.2175%, Up to USD 30 per annum. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class B: Up to 0.2175%, Up to USD 30 per annum. |
| Redemption Fee | Nil.(A 2% charge on redemptions/conversions may be levied where excessive trading by a shareholder is suspected.) | Class A: Nil. Class B: Up to 4.00% |
| Launch Date | 1994/12/30 | 2000/04/03 |
| End of Financial Year | 31/08 | 30/06 |
| Country of Registry | Luxembourg | Luxembourg |
| Other Relevant Information | | |
| |